Avidity
Scott Hager is an accomplished technology executive with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Senior Vice President of Information Technology at Avidity Biosciences, Inc., Scott previously held the position of Chief Information Officer at Jazz Pharmaceuticals and GW Pharmaceuticals, where notable growth in revenues and employee count occurred during their tenure. Other roles include Vice President of Global Commercial Information Technology at Allergan and leadership positions at Valeant Pharmaceuticals and Broadlane, among others. Scott holds a B.S. in Chemical Engineering from Washington University in St. Louis.
This person is not in any teams
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.